Showing 1 - 6 of 6
Background: ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) showed in hypertensive patients that blood pressure-lowering treatment with an amlodipine-based regimen reduces events compared with an atenolol-based regimen and that atorvastatin was more effective than placebo. Abstract: Objective:...
Persistent link: https://www.econbiz.de/10005404770
Compared with olanzapine, the results suggest that quetiapine is cost effective as a maintenance treatment for bipolar depression. </AbstractSection> Copyright Springer International Publishing AG 2012
Persistent link: https://www.econbiz.de/10011001513
<Emphasis Type="Bold">Background: ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) showed in hypertensive patients that blood pressure-lowering treatment with an amlodipine-based regimen reduces events compared with an atenolol-based regimen and that atorvastatin was more effective than placebo. <Emphasis Type="Bold">Objective: To assess...</emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011001519
Objective: To investigate the cost effectiveness of exemestane compared to megestrol in post-menopausal women after tamoxifen failure. Design and setting: A modelling study from the third-party payer perspective in Australia, Belgium, France, Germany, Italy, The Netherlands, Spain and the United...
Persistent link: https://www.econbiz.de/10004990329
Objective: To investigate the relationship between cognitive impairment, measured with the Mini Mental State Examination (MMSE), and the cost of care. Design: The study uses data from the Kungsholmen project, a population-based study in Sweden in which people 75 years and older were observed...
Persistent link: https://www.econbiz.de/10005590274
Background:Background: Bipolar disorder has a significant impact upon a patient's quality of life, imposing a considerable economic burden on the individual, family members and society as a whole. Several medications are indicated for the acute treatment of mania and depression associated with...
Persistent link: https://www.econbiz.de/10010548283